Who's really hypertensive?--Quality control issues in the assessment of blood pressure for randomized trials.
The characterization of blood pressure in treatment trials assessing the benefits of blood pressure lowering regimens is a critical factor for the appropriate interpretation of study results. With numerous operators involved in the measurement of blood pressure in many thousands of patients being screened for entry into clinical trials, it is essential that operators follow pre-defined measurement protocols involving multiple measurements and standardized techniques. Blood pressure measurement protocols have been developed by international societies and emphasize the importance of appropriate choice of cuff size, identification of Korotkoff sounds, and digit preference. Training of operators and auditing of blood pressure measurement may assist in reducing the operator-related errors in measurement. This paper describes the quality control activities adopted for the screening stage of the 2nd Australian National Blood Pressure Study (ANBP2). ANBP2 is cardiovascular outcome trial of the treatment of hypertension in the elderly that was conducted entirely in general practices in Australia. A total of 54 288 subjects were screened; 3688 previously untreated subjects were identified as having blood pressure >140/90 mmHg at the initial screening visit, 898 (24%) were not eligible for study entry after two further visits due to the elevated reading not being sustained. For both systolic and diastolic blood pressure recording, observed digit preference fell within 7 percentage points of the expected frequency. Protocol adherence, in terms of the required minimum blood pressure difference between the last two successive recordings, was 99.8%. These data suggest that adherence to blood pressure recording protocols and elimination of digit preferences can be achieved through appropriate training programs and quality control activities in large multi-centre community-based trials in general practice. Repeated blood pressure measurement prior to initial diagnosis and study entry is essential to appropriately characterize hypertension in these elderly patients.
Reid
Christopher M
CM
Department of Epidemiology and Preventive Medicine, Monash University, Melborne Australia. chris.reid@med.monash.edu.au
Ryan
Philip
P
Miles
Helen
H
Willson
Kristyn
K
Beilin
Laurence J
LJ
Brown
Mark A
MA
Jennings
Garry L
GL
Johnston
Colin I
CI
Macdonald
Graham J
GJ
Marley
John E
JE
McNeil
John J
JJ
Morgan
Trefor O
TO
West
Malcolm J
MJ
Wing
Lindon M H
LM
D000368:Aged; D000369:Aged, 80 and over; D001315:Australia; D001795:Blood Pressure Determination / Q000379:methods / Q000592:standards*; D018660:Blood Pressure Monitoring, Ambulatory / Q000379:methods* / Q000706:statistics & numerical data; D004493:Education / Q000458:organization & administration; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D008403:Mass Screening / Q000379:methods / Q000592:standards*; D008485:Medical Audit; D015337:Multicenter Studies as Topic / Q000592:standards; D011785:Quality Assurance, Health Care / Q000592:standards*; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012107:Research Design